The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of immune cell subsets and cytokine profiles with immune-related hyperinflammatory states after CAR T-cell therapy.
 
Melinda Tan
No Relationships to Disclose
 
Supriya Gupta
No Relationships to Disclose
 
Andre De Menezes Silva Corraes
No Relationships to Disclose
 
Hassan Alkhateeb
No Relationships to Disclose
 
Paschalis Vergidis
No Relationships to Disclose
 
Saad Kenderian
No Relationships to Disclose
 
Jonas Paludo
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst)
Research Funding - Biofourmis (Inst); Karyopharm Therapeutics (Inst)
 
Jose Villasboas
Consulting or Advisory Role - Curio Science (Inst); Kite/Gilead (Inst); Regeneron (Inst); TG Therapeutics (Inst)
Research Funding - Aptose Biosciences (Inst); Celgene/Bristol-Myers Squibb (Inst); Enterome (Inst); Epizyme (Inst); Genentech/Roche (Inst); Regeneron (Inst)
 
Taxiarchis Kourelis
Research Funding - Novartis; Pfizer (Inst)
 
Yucai Wang
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Honoraria - Kite, a Gilead company (Inst)
Consulting or Advisory Role - Abbvie; AstraZeneca (Inst); BeiGene (Inst); Genmab (Inst); Incyte (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Loxo (Inst); TG Therapeutics (Inst)
Research Funding - Abbvie (Inst); BeiGene (Inst); Genentech (Inst); Genmab (Inst); Incyte (Inst); InnoCare (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); MorphoSys (Inst); Novartis (Inst)
 
Morie Gertz
No Relationships to Disclose
 
Suzanne Hayman
No Relationships to Disclose
 
Stephen Ansell
Honoraria - Answers in CME; Medscape; Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Step Pharma (Inst); Takeda (Inst)
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Beigene; Janssen; Pfizer
 
Adrienne Nedved
Honoraria - UpToDate
Other Relationship - Axis Medical Education
 
Robert Wolf
No Relationships to Disclose
 
Patrick Johnston
No Relationships to Disclose
 
Arushi Khurana
No Relationships to Disclose
 
Nelson Leung
Stock and Other Ownership Interests - Abbvie; Senseonics; Verrica Pharmaceuticals
Research Funding - Omeros
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tessera (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)